204 related articles for article (PubMed ID: 17367410)
61. Bruton's tyrosine kinase inhibitors: lessons learned from bench-to-bedside (first) studies.
Ysebaert L; Michallet AS
Curr Opin Oncol; 2014 Sep; 26(5):463-8. PubMed ID: 25033375
[TBL] [Abstract][Full Text] [Related]
62. Inhibition of constitutive activation of STAT3 by curcurbitacin-I (JSI-124) sensitized human B-leukemia cells to apoptosis.
Ishdorj G; Johnston JB; Gibson SB
Mol Cancer Ther; 2010 Dec; 9(12):3302-14. PubMed ID: 21159613
[TBL] [Abstract][Full Text] [Related]
63. Role of oxidative stress in the action of vanadium phosphotyrosine phosphatase inhibitors. Redox independent activation of NF-kappaB.
Krejsa CM; Nadler SG; Esselstyn JM; Kavanagh TJ; Ledbetter JA; Schieven GL
J Biol Chem; 1997 Apr; 272(17):11541-9. PubMed ID: 9111069
[TBL] [Abstract][Full Text] [Related]
64. Enhanced Bruton's Tyrosine Kinase Activity in Peripheral Blood B Lymphocytes From Patients With Autoimmune Disease.
Corneth OBJ; Verstappen GMP; Paulissen SMJ; de Bruijn MJW; Rip J; Lukkes M; van Hamburg JP; Lubberts E; Bootsma H; Kroese FGM; Hendriks RW
Arthritis Rheumatol; 2017 Jun; 69(6):1313-1324. PubMed ID: 28141917
[TBL] [Abstract][Full Text] [Related]
65. Evidence for a protective role of the STAT5 transcription factor against oxidative stress in human leukemic pre-B cells.
Cholez E; Debuysscher V; Bourgeais J; Boudot C; Leprince J; Tron F; Brassart B; Regnier A; Bissac E; Pecnard E; Gouilleux F; Lassoued K; Gouilleux-Gruart V
Leukemia; 2012 Nov; 26(11):2390-7. PubMed ID: 22522791
[TBL] [Abstract][Full Text] [Related]
66. Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes.
Carballo M; Conde M; El Bekay R; Martín-Nieto J; Camacho MJ; Monteseirín J; Conde J; Bedoya FJ; Sobrino F
J Biol Chem; 1999 Jun; 274(25):17580-6. PubMed ID: 10364193
[TBL] [Abstract][Full Text] [Related]
67. Bruton's tyrosine kinase regulates immunoglobulin promoter activation in association with the transcription factor Bright.
Rajaiya J; Hatfield M; Nixon JC; Rawlings DJ; Webb CF
Mol Cell Biol; 2005 Mar; 25(6):2073-84. PubMed ID: 15743806
[TBL] [Abstract][Full Text] [Related]
68. Protein tyrosine kinase Lyn mediates apoptosis induced by topoisomerase II inhibitors in DT40 cells.
Maruo A; Oishi I; Sada K; Nomi M; Kurosaki T; Minami Y; Yamamura H
Int Immunol; 1999 Sep; 11(9):1371-80. PubMed ID: 10464158
[TBL] [Abstract][Full Text] [Related]
69. Structure-activity relationship investigation for benzonaphthyridinone derivatives as novel potent Bruton's tyrosine kinase (BTK) irreversible inhibitors.
Wang B; Deng Y; Chen Y; Yu K; Wang A; Liang Q; Wang W; Chen C; Wu H; Hu C; Miao W; Hur W; Wang W; Hu Z; Weisberg EL; Wang J; Ren T; Wang Y; Gray NS; Liu Q; Liu J
Eur J Med Chem; 2017 Sep; 137():545-557. PubMed ID: 28628824
[TBL] [Abstract][Full Text] [Related]
70. Bruton's tyrosine kinase (Btk) is a useful marker for Hodgkin and B cell non-Hodgkin lymphoma.
Fernández-Vega I; Quirós LM; Santos-Juanes J; Pane-Foix M; Marafioti T
Virchows Arch; 2015 Feb; 466(2):229-35. PubMed ID: 25433814
[TBL] [Abstract][Full Text] [Related]
71. Therapeutic potential of inhibiting Bruton's tyrosine kinase, (BTK).
Vassilev AO; Uckun FM
Curr Pharm Des; 2004; 10(15):1757-66. PubMed ID: 15180538
[TBL] [Abstract][Full Text] [Related]
72. CTLA4 Promotes Tyk2-STAT3-Dependent B-cell Oncogenicity.
Herrmann A; Lahtz C; Nagao T; Song JY; Chan WC; Lee H; Yue C; Look T; Mülfarth R; Li W; Jenkins K; Williams J; Budde LE; Forman S; Kwak L; Blankenstein T; Yu H
Cancer Res; 2017 Sep; 77(18):5118-5128. PubMed ID: 28716895
[TBL] [Abstract][Full Text] [Related]
73. Fatal disseminated mouse adenovirus type 1 infection in mice lacking B cells or Bruton's tyrosine kinase.
Moore ML; McKissic EL; Brown CC; Wilkinson JE; Spindler KR
J Virol; 2004 Jun; 78(11):5584-90. PubMed ID: 15140955
[TBL] [Abstract][Full Text] [Related]
74. Discovery of a potent, covalent BTK inhibitor for B-cell lymphoma.
Wu H; Wang W; Liu F; Weisberg EL; Tian B; Chen Y; Li B; Wang A; Wang B; Zhao Z; McMillin DW; Hu C; Li H; Wang J; Liang Y; Buhrlage SJ; Liang J; Liu J; Yang G; Brown JR; Treon SP; Mitsiades CS; Griffin JD; Liu Q; Gray NS
ACS Chem Biol; 2014 May; 9(5):1086-91. PubMed ID: 24556163
[TBL] [Abstract][Full Text] [Related]
75. B cell responses to oxidative stress.
Tohyama Y; Takano T; Yamamura H
Curr Pharm Des; 2004; 10(8):835-9. PubMed ID: 15032688
[TBL] [Abstract][Full Text] [Related]
76. Cucurbitacin B synergistically enhances the apoptosis-inducing effect of arsenic trioxide by inhibiting STAT3 phosphorylation in lymphoma Ramos cells.
Ding X; Chi J; Yang X; Hao J; Liu C; Zhu C; Wang X; Liu X; Niu Y; Ji W; Chen D; Wu X
Leuk Lymphoma; 2017 Oct; 58(10):2439-2451. PubMed ID: 28278714
[TBL] [Abstract][Full Text] [Related]
77. Bruton's tyrosine kinase as a new therapeutic target.
Uckun FM; Tibbles HE; Vassilev AO
Anticancer Agents Med Chem; 2007 Nov; 7(6):624-32. PubMed ID: 18045057
[TBL] [Abstract][Full Text] [Related]
78. The enhancement by pervanadate of tyrosine phosphorylation on prostatic proteins occurs through the inhibition of membrane-associated tyrosine phosphatases.
Boissonneault M; Chapdelaine A; Chevalier S
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):139-44. PubMed ID: 8927029
[TBL] [Abstract][Full Text] [Related]
79. Identification of oxidative stress-induced tyrosine phosphorylated proteins by immunoprecipitation and mass spectrometry.
Duran MC; Chan HL; Timms JF
Methods Mol Biol; 2009; 527():33-45, ix. PubMed ID: 19241003
[TBL] [Abstract][Full Text] [Related]
80. alpha-thrombin rapidly induces tyrosine phosphorylation of a novel, 74-78-kDa stress response protein(s) in lung fibroblast cells.
Bhat GJ; Samikkannu T; Thomas JJ; Thekkumkara TJ
J Biol Chem; 2004 Nov; 279(47):48915-22. PubMed ID: 15364938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
